Roche funds screening services on South African hospital train:
This article was originally published in Clinica
Cancer screening and preventive diabetes testing are being added to the range of services provided on South Africa's Phelophepa Healthcare Train, thanks to a "substantial" increase in sponsorship funding by Roche. Screening for breast cancer and type-2 diabetes in particular will fit in well with the train's biannual, week-long visits to each of the locations it covers. The train does not provide ongoing care, but refers cases to the relevant hospitals. Since its launch 10 years ago, it has provided primary healthcare cover to around seven million people in regions with inadequate access to medical services. Roche is the Phelophepa's leading sponsor outside South Africa.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.